Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Strategic Asset Allocation Index
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited strategic asset allocation index. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Strategic Asset Allocation Index of 19.1% as of June 2023. Strategic assets (PP&E of €6.77 Billion plus long-term investments of €-) total €6.77 Billion, measured against net assets of €35.38 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Guangzhou Baiyunshan Pharmaceutical Hold's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2022)
Strategic asset allocation index of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2022. This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 19.1%, representing strategic assets of €6.77 Billion against net assets of €35.38 Billion EUR. Check Guangzhou Baiyunshan Pharmaceutical Hold (GU5) tangible net worth to evaluate the tangible quality of the company's equity base.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Strategic Asset Allocation Index by Year (2013–2022)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangzhou Baiyunshan Pharmaceutical Hold (GU5) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.5% | €6.57 Billion | €6.57 Billion | €- | €33.64 Billion | ▲ +1.4 pp |
| 2021 | 18.1% | €5.68 Billion | €5.68 Billion | €- | €31.33 Billion | ▲ +0.1 pp |
| 2020 | 18.1% | €5.10 Billion | €5.10 Billion | €- | €28.21 Billion | ▲ +1.0 pp |
| 2019 | 17.1% | €4.44 Billion | €4.44 Billion | €- | €25.99 Billion | ▼ -7.6 pp |
| 2018 | 24.7% | €5.72 Billion | €3.65 Billion | €2.07 Billion | €23.14 Billion | ▼ -3.4 pp |
| 2017 | 28.1% | €5.41 Billion | €2.37 Billion | €3.05 Billion | €19.26 Billion | ▼ -0.1 pp |
| 2016 | 28.2% | €4.98 Billion | €2.36 Billion | €2.62 Billion | €17.65 Billion | ▼ -28.6 pp |
| 2015 | 56.8% | €4.93 Billion | €2.49 Billion | €2.44 Billion | €8.68 Billion | ▲ +1.6 pp |
| 2014 | 55.2% | €4.37 Billion | €2.29 Billion | €2.08 Billion | €7.92 Billion | ▼ -2.6 pp |
| 2013 | 57.8% | €4.06 Billion | €2.07 Billion | €1.99 Billion | €7.02 Billion | — |